SMS Pharmaceuticals Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, to the stock exchanges. This certificate, received from their Registrar and Share Transfer Agent, M/s. Aarthi Consultants Private Limited, confirms compliance for the quarter ended June 30, 2026. The company and its RTA have confirmed that all actions required for the dematerialization of securities were completed within 15 days of receiving the certificates from depository participants during the period from April 1, 2026, to June 30, 2026. This includes the mutilation and cancellation of original certificates, and updating the records to reflect the depository as the registered owner. The securities involved are listed on the stock exchanges.
